VPGMarketResearchs new report provides comprehensive analysis of thePOC hematology and flow cytometry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
- Review of POC hematology and flow cytometry market segments, including their dynamics, trends, structure, size, growth and major suppliers.
- Five-year test volume and reagent sales forecasts forhematology and flow cytometry procedures by market segment:
- Physician Offices/Group Practices- Emergency Rooms- Operating/Recovery Suites- ICUs/CCUs- Cancer Clinics- Ambulatory Care Centers- Surgery Centers- Nursing Homes- Birth Centers
Sales and Market Share Analysis
- Sales and market shares ofmajor reagent and instrument suppliers.
Routine and Special Hematology Tests
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils and others.
Flow Cytometry Tests
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.
- Emerging technologies and their applications for POC testing.- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.- Design criteria for POC testing products.- Alternative business expansion strategies.- Potential market entry barriers and risks.
- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
- The companies analyzed in the report include:
- Abbott - ADI/American Diagnostica - Agilent Technologies - Alere/Biosite/Inverness - Axis-Shield - Beckman Coulter/Danaher - Becton Dickinson - Bio/Data - Biomerieux - Bio-Rad - Cepheid - Chrono-Log - Corgenix - Decode Genetics - Diadexus - Diagnocure - Diagnostica Stago/Trinity Biotech - Diamedix/Erba - Diasorin - Eiken Chemical - EKF Diagnostics - Fujirebio - Grifols - Helena Laboratories - Hologic/Gen-Probe - Horiba - Instrumentation Laboratory - International Technidyne/Nexus DX - Kreatech/Leica - Kyowa Medex - Lonza - Mackay Life Sciences - Matritech - Nihon Kohden - Ortho-Clinical Diagnostics - Polartechnics - Polymedco - Qiagen - Roche - SDIX - Sequenom - Siemens - Sienco - Sysmex - Takara Bio - ThermoFisher - Tosoh - Wako - Zycare/Alere
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.
Contains 279 pages and58 tables